Shariah compliance overview
Not HalalNeoGenomics, Inc. (NEO) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services.
NeoGenomics, Inc. (NEO) operates in the Healthcare sector, in the Medical - Diagnostics & Research industry.
Why it is not classified as halal: it does not pass these screens: Interest-bearing debt, Interest-bearing securities and assets.
- Business Activity
- 1.24%Limit 5%Pass
- Interest-bearing debt
- 125.64%Limit 30%Fail
- Interest-bearing securities and assets
- 48.98%Limit 30%Fail
- Dividend purification
- 1.24%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about NeoGenomics, Inc. (NEO). Current Akinda screening label: Not Halal.
